Literature DB >> 22993629

Antiviral effects of dehydroascorbic acid.

Misao Uozaki1, Keiko Ikeda, Kazuko Tsujimoto, Mitsunori Nishide, Hisashi Yamasaki, Boonruang Khamsri, A Hajime Koyama.   

Abstract

IN THE PRESENT STUDY, DEHYDROASCORBIC ACID INHIBITED THE MULTIPLICATION OF VIRUSES OF THREE DIFFERENT FAMILIES: herpes simplex virus type 1 (HSV-1), influenza virus type A and poliovirus type 1. Although dehydroascorbic acid showed some cytotoxicity at higher concentrations, the observed antiviral activity was not the secondary result of the cytotoxic effect of the reagent, as the inhibition of virus multiplication was observed at reagent concentrations significantly lower than those resulting in cytotoxicity. Characterization of the mode of the antiviral action of dehydroascorbic acid against HSV-1 revealed that the addition of reagent at any time post infection inhibited the formation of progeny infectious virus in the infected cells, and a one-step growth curve showed that the addition of reagent allowed formation for an additional 2 h, but then almost completely suppressed it. These results indicate that the reagent inhibits HSV-1 multiplication after the completion of viral DNA replication, probably at the step of the envelopment of viral nucleocapsids at the Golgi apparatus of infected cells.

Entities:  

Year:  2010        PMID: 22993629      PMCID: PMC3446724          DOI: 10.3892/etm.2010.139

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  17 in total

1.  Suppression of apoptotic and necrotic cell death by poliovirus.

Authors:  A Hajime Koyama; Hiroshi Irie; Fumiko Ueno; Motomi Ogawa; Akio Nomoto; Akio Adachi
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

2.  Herpes simplex virus 1 envelopment follows two diverse pathways.

Authors:  Helene Leuzinger; Urs Ziegler; Elisabeth M Schraner; Cornel Fraefel; Daniel L Glauser; Irma Heid; Mathias Ackermann; Martin Mueller; Peter Wild
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Antiviral effect of octyl gallate against DNA and RNA viruses.

Authors:  Misao Uozaki; Hisashi Yamasaki; Yukiko Katsuyama; Masanori Higuchi; Tomihiko Higuti; A Hajime Koyama
Journal:  Antiviral Res       Date:  2006-08-22       Impact factor: 5.970

4.  Antiviral effect of octyl gallate against influenza and other RNA viruses.

Authors:  Hisashi Yamasaki; Misao Uozaki; Yukiko Katsuyama; Hirotoshi Utsunomiya; Tsutomu Arakawa; Masanori Higuchi; Tomihiko Higuti; A Hajime Koyama
Journal:  Int J Mol Med       Date:  2007-04       Impact factor: 4.101

5.  Dehydroascorbic acid irreversibly inhibits hexokinase activity.

Authors:  M Fiorani; R De Sanctis; F Scarlatti; L Vallorani; R De Bellis; G Serafini; M Bianchi; V Stocchi
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

6.  Effect of caffeine on the multiplication of DNA and RNA viruses.

Authors:  Masaki Murayama; Kazuko Tsujimoto; Misao Uozaki; Yukiko Katsuyama; Hisashi Yamasaki; Hirotoshi Utsunomiya; A Hajime Koyama
Journal:  Mol Med Rep       Date:  2008 Mar-Apr       Impact factor: 2.952

7.  Antiviral effect of pyridinium formate, a novel component of coffee extracts.

Authors:  Kazuko Tsujimoto; Chiseko Sakuma; Misao Uozaki; Hisashi Yamasaki; Hirotoshi Utsunomiya; Kitaro Oka; A Hajime Koyama
Journal:  Int J Mol Med       Date:  2010-03       Impact factor: 4.101

8.  Antiviral effects of ascorbic and dehydroascorbic acids in vitro.

Authors:  Ayami Furuya; Misao Uozaki; Hisashi Yamasaki; Tsutomu Arakawa; Mikio Arita; A Hajime Koyama
Journal:  Int J Mol Med       Date:  2008-10       Impact factor: 4.101

9.  Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta.

Authors:  Juan M Cárcamo; Alicia Pedraza; Oriana Bórquez-Ojeda; Bing Zhang; Roberto Sanchez; David W Golde
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Effect of ionic strength on the binding of ascorbate to albumin.

Authors:  Evgenia Lozinsky; Artem Novoselsky; Robert Glaser; Alexander I Shames; Gertz I Likhtenshtein; Dan Meyerstein
Journal:  Biochim Biophys Acta       Date:  2002-07-03
View more
  7 in total

1.  In vitro anti-influenza assessment of anionic compounds ascorbate, acetate and citrate.

Authors:  Hadiseh Shokouhi Targhi; Parvaneh Mehrbod; Fatemeh Fotouhi; Mehriar Amininasab
Journal:  Virol J       Date:  2022-05-23       Impact factor: 5.913

2.  Survival of influenza A virus on contaminated student clothing.

Authors:  Keiko Ikeda; Kazuko Tsujimoto; Yukiko Suzuki; Augustine Hajime Koyama
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

Review 3.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 4.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

5.  2-Year-Old and 3-Year-Old Italian ALS Patients with Novel ALS2 Mutations: Identification of Key Metabolites in Their Serum and Plasma.

Authors:  Mukesh Gautam; Renata Del Carratore; Benjamin Helmold; Alessandra Tessa; Oge Gozutok; Navdeep Chandel; Halil Idrisoglu; Paolo Bongioanni; Roberta Battini; P Hande Ozdinler
Journal:  Metabolites       Date:  2022-02-12

Review 6.  Vitamin C in Stem Cell Biology: Impact on Extracellular Matrix Homeostasis and Epigenetics.

Authors:  Cristina D'Aniello; Federica Cermola; Eduardo Jorge Patriarca; Gabriella Minchiotti
Journal:  Stem Cells Int       Date:  2017-04-20       Impact factor: 5.443

7.  Medical-Grade Honey Outperforms Conventional Treatments for Healing Cold Sores-A Clinical Study.

Authors:  Piyu Parth Naik; Dimitris Mossialos; Bas van Wijk; Petra Novakova; Frank A D T G Wagener; Niels A J Cremers
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.